Manjistha Sengupta

961 total citations
18 papers, 543 citations indexed

About

Manjistha Sengupta is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, Manjistha Sengupta has authored 18 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Neurology. Recurrent topics in Manjistha Sengupta's work include Occupational and environmental lung diseases (6 papers), Myasthenia Gravis and Thymoma (4 papers) and Cancer Research and Treatments (3 papers). Manjistha Sengupta is often cited by papers focused on Occupational and environmental lung diseases (6 papers), Myasthenia Gravis and Thymoma (4 papers) and Cancer Research and Treatments (3 papers). Manjistha Sengupta collaborates with scholars based in United States, India and Germany. Manjistha Sengupta's co-authors include Stuart Austin, Raffit Hassan, Linda L. Kusner, Henry J. Kaminski, Hans Jørgen Nielsen, Brenda Youngren, Asis Datta, Azam Ghafoor, Betsy Morrow and Jingli Zhang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Manjistha Sengupta

18 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manjistha Sengupta United States 13 174 119 92 92 79 18 543
Takashi Murakami Japan 17 401 2.3× 66 0.6× 154 1.7× 36 0.4× 75 0.9× 45 817
Kortine Kleinheinz Germany 5 255 1.5× 96 0.8× 133 1.4× 19 0.2× 18 0.2× 6 610
H. Becker Germany 15 333 1.9× 57 0.5× 206 2.2× 93 1.0× 27 0.3× 28 767
Garry M. Marley United States 11 170 1.0× 97 0.8× 101 1.1× 94 1.0× 104 1.3× 11 641
Yulin Shou United States 11 191 1.1× 27 0.2× 42 0.5× 93 1.0× 43 0.5× 16 438
Elias A. Rahal Lebanon 15 157 0.9× 12 0.1× 93 1.0× 49 0.5× 149 1.9× 48 653
Yao Fang China 15 252 1.4× 88 0.7× 69 0.8× 23 0.3× 106 1.3× 48 734
Christelle Bahlawane Luxembourg 12 224 1.3× 41 0.3× 40 0.4× 108 1.2× 71 0.9× 16 625
Shuangyou Liu China 13 197 1.1× 16 0.1× 286 3.1× 72 0.8× 94 1.2× 31 676
Manuela Vici Italy 13 476 2.7× 96 0.8× 159 1.7× 59 0.6× 39 0.5× 23 799

Countries citing papers authored by Manjistha Sengupta

Since Specialization
Citations

This map shows the geographic impact of Manjistha Sengupta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manjistha Sengupta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manjistha Sengupta more than expected).

Fields of papers citing papers by Manjistha Sengupta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manjistha Sengupta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manjistha Sengupta. The network helps show where Manjistha Sengupta may publish in the future.

Co-authorship network of co-authors of Manjistha Sengupta

This figure shows the co-authorship network connecting the top 25 collaborators of Manjistha Sengupta. A scholar is included among the top collaborators of Manjistha Sengupta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manjistha Sengupta. Manjistha Sengupta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Venugopalan, Abhilash, Jingli Zhang, Nishanth Ulhas Nair, et al.. (2024). Persistence of activated anti‐mesothelin hYP218 chimeric antigen receptor T cells in the tumour is associated with efficacy in gastric and colorectal carcinomas. Clinical and Translational Medicine. 14(11). e70057–e70057. 3 indexed citations
2.
Nair, Nishanth Ulhas, Qun Jiang, Jun S. Wei, et al.. (2023). Genomic and transcriptomic analyses identify a prognostic gene signature and predict response to therapy in pleural and peritoneal mesothelioma. Cell Reports Medicine. 4(2). 100938–100938. 11 indexed citations
3.
Tomar, Sakshi, Jingli Zhang, Manakamana Khanal, et al.. (2022). Development of Highly Effective Anti-Mesothelin hYP218 Chimeric Antigen Receptor T Cells With Increased Tumor Infiltration and Persistence for Treating Solid Tumors. Molecular Cancer Therapeutics. 21(7). 1195–1206. 31 indexed citations
4.
Hu, Zishuo I., Azam Ghafoor, Manjistha Sengupta, & Raffit Hassan. (2021). Malignant mesothelioma: Advances in immune checkpoint inhibitor and mesothelin‐targeted therapies. Cancer. 127(7). 1010–1020. 23 indexed citations
5.
Ghafoor, Azam, Idrees Mian, Betsy Morrow, et al.. (2021). Phase 2 Study of Olaparib in Malignant Mesothelioma and Correlation of Efficacy With Germline or Somatic Mutations in BAP1 Gene. JTO Clinical and Research Reports. 2(10). 100231–100231. 33 indexed citations
6.
Jiang, Qun, Azam Ghafoor, Idrees Mian, et al.. (2020). Enhanced efficacy of mesothelin-targeted immunotoxin LMB-100 and anti–PD-1 antibody in patients with mesothelioma and mouse tumor models. Science Translational Medicine. 12(550). 35 indexed citations
7.
Khanal, Manakamana, Junko Murai, Jingli Zhang, et al.. (2020). Sensitivity of Mesothelioma Cells to PARP Inhibitors Is Not Dependent on BAP1 but Is Enhanced by Temozolomide in Cells With High-Schlafen 11 and Low-O6-methylguanine-DNA Methyltransferase Expression. Journal of Thoracic Oncology. 15(5). 843–859. 54 indexed citations
8.
Hassan, Raffit, Idrees Mian, Emerson Padiernos, et al.. (2020). Phase II study of olaparib in malignant mesothelioma (MM) to correlate efficacy with germline and somatic mutations in DNA repair genes.. Journal of Clinical Oncology. 38(15_suppl). 9054–9054. 12 indexed citations
9.
Khanal, Manakamana, Junko Murai, Qun Jiang, et al.. (2019). MA12.03 PARP Inhibitor Sensitivity Does Not Depend on BAP1 but Is Enhanced by Temozolomide in MGMT Deficient Human Mesothelioma Cells. Journal of Thoracic Oncology. 14(10). S296–S296. 1 indexed citations
10.
Kusner, Linda L., Kristina Yucius, Manjistha Sengupta, et al.. (2019). Investigational RNAi Therapeutic Targeting C5 Is Efficacious in Pre-clinical Models of Myasthenia Gravis. Molecular Therapy — Methods & Clinical Development. 13. 484–492. 42 indexed citations
11.
Sengupta, Manjistha, Bi‐Dar Wang, Norman H. Lee, et al.. (2018). MicroRNA and mRNA expression associated with ectopic germinal centers in thymus of myasthenia gravis. PLoS ONE. 13(10). e0205464–e0205464. 19 indexed citations
12.
Kusner, Linda L., Manjistha Sengupta, & Henry J. Kaminski. (2018). Acetylcholine receptor antibody–mediated animal models of myasthenia gravis and the role of complement. Annals of the New York Academy of Sciences. 1413(1). 136–142. 15 indexed citations
13.
Gupta, Varsha, Manjistha Sengupta, Jaya Prakash, & Baishnab C. Tripathy. (2016). Basic and Applied Aspects of Biotechnology. DIAL (Catholic University of Leuven). 22 indexed citations
14.
Sengupta, Manjistha, et al.. (2014). Serum Metabolomic Response of Myasthenia Gravis Patients to Chronic Prednisone Treatment. PLoS ONE. 9(7). e102635–e102635. 17 indexed citations
15.
Ghosh, Swagata, et al.. (2011). Two gene clusters co‐ordinate for a functional N‐acetylglucosamine catabolic pathway in Vibrio cholerae. Molecular Microbiology. 80(6). 1549–1560. 34 indexed citations
16.
Sengupta, Manjistha & Stuart Austin. (2011). Prevalence and Significance of Plasmid Maintenance Functions in the Virulence Plasmids of Pathogenic Bacteria. Infection and Immunity. 79(7). 2502–2509. 118 indexed citations
17.
Sengupta, Manjistha, Hans Jørgen Nielsen, Brenda Youngren, & Stuart Austin. (2009). P1 Plasmid Segregation: Accurate Redistribution by Dynamic Plasmid Pairing and Separation. Journal of Bacteriology. 192(5). 1175–1183. 61 indexed citations
18.
Sengupta, Manjistha & Asis Datta. (2003). Two membrane proteins located in the Nag regulon of Candida albicans confer multidrug resistance. Biochemical and Biophysical Research Communications. 301(4). 1099–1108. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takashi Murakami Breakdown of academic impact, for papers by Kortine Kleinheinz Breakdown of academic impact, for papers by H. Becker Breakdown of academic impact, for papers by Garry M. Marley Breakdown of academic impact, for papers by Yulin Shou Breakdown of academic impact, for papers by Elias A. Rahal Breakdown of academic impact, for papers by Yao Fang Breakdown of academic impact, for papers by Christelle Bahlawane Breakdown of academic impact, for papers by Shuangyou Liu Breakdown of academic impact, for papers by Manuela Vici
Rankless by CCL
2026